Accu-Med Corp.

Accu-Med Corp. specializes in devices for microbial analysis. Their primary product, the ACCU-CULSHURE™, is designed for culturing and analyzing microbial samples, which is useful in clinical or research environments for identifying pathogens. This device falls under the broader category of diagnostic tools for microbiology.

Accu-Med Corp. is based in the United States. Since the U.S. Food and Drug Administration (FDA) oversees medical device regulation in the country, the company’s devices—such as the ACCU-CULSHURE™—must comply with FDA requirements. The location ensures alignment with U.S. regulatory frameworks, including classification and clearance processes like the 510(k) pathway.

The ACCU-CULSHURE™ from Accu-Med Corp. is classified as a Class I device under FDA regulations. This classification is typically assigned to devices posing minimal risk to users, such as general-purpose tools or low-risk diagnostic products. Class I devices often require general controls (e.g., good manufacturing practices) but may not need pre-market approval, depending on their specific use.

Accu-Med Corp.’s devices, including the ACCU-CULSHURE™, are listed in the FDA’s 510(k) clearance database. This registry tracks devices that have undergone the 510(k) premarket notification process, demonstrating that the manufacturer has shown their device is substantially equivalent to a legally marketed predicate device. This listing helps healthcare providers and regulators verify compliance and authorization status.